STONE HEISZ LESLIE 4
4 · Edwards Lifesciences Corp · Filed Feb 8, 2024
Insider Transaction Report
Form 4
STONE HEISZ LESLIE
Director
Transactions
- Exercise/Conversion
Director Stock Option (Right to Acquire)
2024-02-08−7,056→ 0 totalExercise: $36.86From: 2017-05-12Exp: 2024-05-11→ Common Stock (7,056 underlying) - Exercise/Conversion
Common Stock
2024-02-08$36.86/sh+7,056$260,107→ 34,036 total - Sale
Common Stock
2024-02-08$86.45/sh−7,056$609,991→ 26,980 total